Results 231 to 240 of about 43,205 (262)

Periostin and Dipeptidyl Peptidase-4

Immunology and Allergy Clinics of North America, 2018
Claire Emson, Tuyet-Hang Pham, Scott Manetz, Paul Newbold   +3 more
openaire   +1 more source

Dipeptidyl Peptidase-4 Inhibitors

2014
Ranjit Unnikrishnan, Viswanathan Mohan, Gaurav Beswal   +2 more
openaire   +1 more source

Inhibitors of Dipeptidyl Peptidase 4

2005
Stephen L. Gwaltney, Jeffrey A. Stafford
openaire   +1 more source

Dipeptidyl peptidase-4 (DPP-4)

Science-Business eXchange, 2012
openaire   +1 more source

Extraenzymatic functions of the dipeptidyl peptidase IV-related proteins DP8 and DP9 in cell adhesion, migration and apoptosis

FEBS Journal, 2006
Mark D. Gorrell, Denise M T Yu
exaly  

A Role for Dipeptidyl Peptidase IV in Suppressing the Malignant Phenotype of Melanocytic Cells

Journal of Experimental Medicine, 1999
Anthony P Albino, Alan N Houghton, A P Albino   +2 more
exaly  

Dipeptidyl peptidase IV inhibitors, a risk factor for bullous pemphigoid: Retrospective multicenter case-control study from France and Switzerland

Journal of the American Academy of Dermatology, 2018
Simone Cazzaniga, Marie Aleth Richard, René Valero   +2 more
exaly  

Dipeptidyl Peptidase-4 in Cariometabolic Disease

The cardiovascular implications of modulating cell specific expression of the serine protease dipeptidyl peptidase-4 (DPP4) were investigated in a series of murine models of metabolic dysfunction-associated steatotic liver disease (MASLD), cardiometabolic disease and myocardial infarction. In vivo experiments were conducted using several genetic models,
openaire   +1 more source

Safety of dipeptidyl peptidase-4 inhibitors: a meta-analysis of randomized clinical trials

Current Medical Research and Opinion, 2011
Matteo Monami, Edoardo Mannucci, Ilaria Dicembrini   +2 more
exaly  

Interactive Hemodynamic Effects of Dipeptidyl Peptidase-IV Inhibition and Angiotensin-Converting Enzyme Inhibition in Humans

Hypertension, 2010
Nancy J. Brown
exaly